We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$225B
1-Year Est. Return
49.49%
This Fund
S&P 500
This Quarter
Est. Return
+11.74%
1 Year Est. Return
+49.49%
3 Year Est. Return
+172.58%
5 Year Est. Return
+223.9%
10 Year Est. Return
+876%
AUM
$71.5B
AUM Growth
+$3.66B
(+5.4%)
Cap. Flow
-$2.85B
Cap. Flow
% of AUM
-3.99%
Top 10 Holdings %
Top 10 Hldgs %
18.22%
Holding
1,538
New
294
Increased
526
Reduced
448
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$268M |
| 2 |
General Motors
GM
|
+$263M |
| 3 |
AstraZeneca
AZN
|
+$235M |
| 4 |
Vale
VALE
|
+$226M |
| 5 |
Oracle
ORCL
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$945M |
| 2 |
Microsoft
MSFT
|
+$606M |
| 3 |
Canadian Natural Resources
CNQ
|
+$552M |
| 4 |
Bank of America
BAC
|
+$490M |
| 5 |
AbbVie
ABBV
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.7% |
| 2 | Healthcare | 20.13% |
| 3 | Consumer Discretionary | 15.62% |
| 4 | Financials | 9.5% |
| 5 | Energy | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Hovnanian Enterprises
HOV
$799M
| $1.09M | ﹤0.01% |
+25,818
| New | +$1.09M |
|
1002
Nu Skin
NUS
$236M
| $1.09M | ﹤0.01% |
+25,760
| New | +$991K |
|
|
LGF.A
1003
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $1.08M | ﹤0.01% |
189,459
-32,640
| -15% | -$231K |
|
1004
Ollie's Bargain Outlet
OLLI
$4.7B
| $1.08M | ﹤0.01% |
+22,964
| New | +$1.24M |
|
1005
Broadridge
BR
$19.6B
| $1.07M | ﹤0.01% |
7,951
+6,180
| +349% | +$878K |
|
1006
Genie Energy
GNE
$386M
| $1.06M | ﹤0.01% |
102,783
+71,450
| +228% | +$696K |
|
1007
Stoneridge
SRI
$201M
| $1.06M | ﹤0.01% |
+48,964
| New | +$1.05M |
|
|
SLCA
1008
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $1.05M | ﹤0.01% |
84,082
+3,621
| +5% | +$46.4K |
|
1009
Werner Enterprises
WERN
$2.31B
| $1.04M | ﹤0.01% |
+25,958
| New | +$1.06M |
|
|
OSG
1010
Octave Specialty Group
OSG
$212M
| $1.04M | ﹤0.01% |
+59,868
| New | +$889K |
|
|
ONTF
1011
DELISTED
ON24
ONTF
| $1.04M | ﹤0.01% |
121,000
+30,976
| +34% | +$248K |
|
1012
Magnite
MGNI
$3.53B
| $1.04M | ﹤0.01% |
+98,394
| New | +$898K |
|
1013
Noodles & Co
NDLS
$100M
| $1.04M | ﹤0.01% |
23,656
-1,339
| -5% | -$58.7K |
|
1014
Invesco Mortgage Capital
IVR
$805M
| $1.03M | ﹤0.01% |
81,265
-61,513
| -43% | -$752K |
|
1015
VICI Properties
VICI
$29B
| $1.03M | ﹤0.01% |
+31,948
| New | +$1.03M |
|
1016
Rithm Capital
RITM
$5.79B
| $1.03M | ﹤0.01% |
+126,410
| New | +$1.06M |
|
1017
Eaton
ETN
$176B
| $1.03M | ﹤0.01% |
6,544
-1,153
| -15% | -$177K |
|
1018
Timken Company
TKR
$9.1B
| $1.02M | ﹤0.01% |
+14,468
| New | +$1.01M |
|
|
CCC
1019
CCC Intelligent Solutions
CCC
$4.19B
| $1.02M | ﹤0.01% |
117,184
+86,907
| +287% | +$775K |
|
1020
UNIFI
UFI
$120M
| $1.02M | ﹤0.01% |
118,328
+91,478
| +341% | +$787K |
|
1021
Intercorp Financial Services
IFS
$6.04B
| $1.02M | ﹤0.01% |
+43,319
| New | +$1M |
|
1022
Ball Corp
BALL
$16.4B
| $1.02M | ﹤0.01% |
+19,867
| New | +$1.03M |
|
1023
Ingevity
NGVT
$2.59B
| $1.01M | ﹤0.01% |
+14,401
| New | +$1.02M |
|
1024
Aon
AON
$75.7B
| $1M | ﹤0.01% |
+3,345
| New | +$977K |
|
1025
International Bancshares
IBOC
$4.57B
| $1M | ﹤0.01% |
21,906
-108,077
| -83% | -$5.2M |
|
Similar funds
Arrowstreet Capital's Q4 2022 Portfolio in Review
As of Q4 2022, Arrowstreet Capital held 1,538 positions worth $71.5B, up 5.4% from $67.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $2.85B in Q4 2022, closing 234 positions and reducing 448 holdings. Its most notable exit was AbbVie, an estimated $432M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Gerdau worth $105M.
- Arrowstreet Capital's largest Q4 2022 buy was Gerdau: 23,855,591 shares worth $105M.
- Arrowstreet Capital added most to Visa in Q4 2022, an estimated $268M increase.
- Arrowstreet Capital's biggest Q4 2022 reduction was JPMorgan Chase, cutting an estimated $945M.
- Arrowstreet Capital fully exited AbbVie in Q4 2022, selling an estimated $432M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $71.5B portfolio in Q4 2022.
- Arrowstreet Capital opened 294 new positions and closed 234 in Q4 2022.
- Arrowstreet Capital's portfolio value rose 5.4% quarter-over-quarter to $71.5B.
Based on Arrowstreet Capital's 13F filing for Q4 2022, filed 14 Feb 2023.